ProteoNic Biosciences partnered with Ginkgo Bioworks (NYSE:DNA), the alliance will grant Ginkgo Bioworks' (DNA) customers access to ProteoNic's vector technology in the field of protein production and ...

Indiana’s Applied Research Institute secured another massive economic development win for the state Monday after a federal agency designated Heartland BioWorks, a group of Indiana stakeholders, as a ...

Foremost aims to commercialize a technology that can convert dairy manufacturing co-products into environmentally friendly, value-added materials The partners aim to reduce the dairy industry's carbon ...

We live in the age of the elevator pitch, catchy soundbites, and companies promising to revolutionize every industry under the sun. No other field attracts more visionaries than healthcare. After all, ...

The MarketWatch News Department was not involved in the creation of this content. Leiden, The Netherlands -- 11 December 2025 -- ProteoNic BV, a leading provider of premium vector technology for ...

Jason Kelly, CEO of Ginkgo Bioworks: "I'm excited to see how the community builds on top of these models and our API. AA-0 is the first model we have released trained on Ginkgo's proprietary data – we ...

Bio-Works Technologies AB Bio-Works Technologies AB engages in the research and development, manufacturing, and supply of agarose-based resins. Its products include Size Exclusion and Ion Exchange ...

Ginkgo Bioworks' technology makes it easier to engineer new microorganisms. Palantir used to cater largely to government intelligence agencies, but it's in the midst of an ongoing effort to balance ...

Leiden, The Netherlands – 11 December 2025 – ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G ...